Functional deficiency of circadian regulator PER2 enhances breast cancer susceptibility and progression with immunosuppression
Open Access
- 12 August 2026
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 45 (40) , 4269-4283
Abstract
Circadian rhythm (CR) governs systemic and tissue physiological homeostasis by regulating sleep-wake cycles, hormone secretion, and metabolism. CR disruption (CRD), such as shift work, has been associated with increased cancer risk, particularly female breast cancer (BC), yet the mechanisms underlying breast tumorigenesis and immunosuppression resulting from a specific clock gene dysfunction remain unclear. Here, we identify that circadian regulator Period 2 (PER2) is significantly downregulated in BC and correlates with poor prognosis. PER2 functional deficiency mice ( PAS-B domain deletion, Per2 m/m ) display high susceptibility to DMBA/MPA-induced breast tumors. Tumor microenvironment (TME) profiling reveals that compared with Per2 wt tumors induced in Per2 wt mice, Per2 m/m tumors generated in Per2 m/m mice show reduced CD8⁺ T cells and M1-like macrophages infiltration and increased Foxp3 + Tregs and M2-like macrophages. Of note, reciprocal transplantation of Per2 m/m and Per2 wt tumors into Per2 wt or Per2 m/m mouse hosts reveals that systemic PER2 functional deficiency status not only boosts tumor growth but also promotes immunosuppression in TME. Consistently, Per2 knockdown in tumor cells enhances tumor cell proliferation and immune evasion in WT hosts. Mechanistically, PER2 knockdown leads to aberrant CLOCK transactivation, which upregulates the co-expression of HER2 and CD47, thereby leading to tumor aggressive growth with limited macrophage immune checkpoint surveillance. Collectively, our findings suggest that PER2 functional deficiency-driven CLOCK-HER2/CD47 axis promotes BC susceptibility and tumor immunosuppression, which provides a potential therapeutic target to mitigate CRD-associated BC risk and aggressiveness.Keywords
Funding Information
- Division of Cancer Epidemiology and Genetics (CA213830)
This publication has 64 references indexed in Scilit:
- Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacyCell, 2024
- The antitumor activities of anti-CD47 antibodies require Fc-FcγR interactionsCancer Cell, 2023
- Relationship Between Breast Cancer Risk and Polymorphisms in CLOCK Gene: A Systematic Review and Meta-AnalysisBiochemical Genetics, 2023
- Circadian regulator CLOCK promotes tumor angiogenesis in glioblastomaCell Reports, 2023
- Circadian rhythm disrupting behaviours and cancer outcomes in breast cancer survivors: a systematic reviewBreast Cancer Research and Treatment, 2022
- KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung CancerCancer Cell, 2020
- Mutation of the Human Circadian Clock Gene CRY1 in Familial Delayed Sleep Phase DisorderCell, 2017
- Circadian Rhythm Disruption Promotes Lung TumorigenesisCell Metabolism, 2016
- Association of sleep duration and breast cancer OncotypeDX recurrence scoreBreast Cancer Research and Treatment, 2012
- Distinct migration patterns of naive and effector CD8 T cells in the spleen: correlation with CCR7 receptor expression and chemokine reactivityEuropean Journal of Immunology, 1999